VTYXVentyx Biosciences, Inc.

VTYX Stock Price, Valuation & Chart | Ventyx Biosciences, Inc.

Compare

$14.000+0.00 (+0.00%)

At close · 06 Mar 2026, 02:30 pm

Sector: Healthcare Industry: Biotechnology VTYX intrinsic value VTYX calculated fair value vs price

Overview Financials Dividends Ratios

VTYX Historical price chart

VTYX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.00B

PE Ratio-9.4

EPS-1.49

Trading Volume5.40M

Today's High/Low14.0/14.0

Dividend Yield0.00

52 Week High/Low25.0/0.78

Shares Outstanding71.75M

VTYX Financial Statement

VTYX Analyst ratings

VTYX Analysis & performance metrics

VTYX Company profile

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The…

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic…

VTYX Management team

Name

Position

Roy M. Gonzales CPA, M.B.A.

Senior Vice President of Finance and Principal Financial & Accounting Officer

Mark S. Forman M.D., Ph.D.

Chief Medical Officer

Sheila K. Gujrathi M.D.

Executive Chairperson

John M. Nuss Ph.D.

Chief Scientific Officer

Kathy Ogilvie Ph.D.

Senior Vice President of Translational & Nonclinical Research

Raju S. Mohan Ph.D.CEO

Founder, Chief Executive Officer, President & Director

Matthew Richard MooreCOO

Chief Operating Officer

Snehal Naik Ph.D.

Senior Vice President of Clinical Development

Name

Position

Roy M. Gonzales CPA, M.B.A.

Senior Vice President of Finance and Principal Financial & Accounting Officer

Mark S. Forman M.D., Ph.D.

Chief Medical Officer

Sheila K. Gujrathi M.D.

Executive Chairperson

John M. Nuss Ph.D.

Chief Scientific Officer

Kathy Ogilvie Ph.D.

Senior Vice President of Translational & Nonclinical Research

Raju S. Mohan Ph.D.CEO

Founder, Chief Executive Officer, President & Director

Matthew Richard MooreCOO

Chief Operating Officer

Snehal Naik Ph.D.

Senior Vice President of Clinical Development

Management Team

Roy M. Gonzales CPA, M.B.A.

Senior Vice President of Finance and Principal Financial & Accounting Officer

Mark S. Forman M.D., Ph.D.

Chief Medical Officer

Sheila K. Gujrathi M.D.

Executive Chairperson

John M. Nuss Ph.D.

Chief Scientific Officer

Kathy Ogilvie Ph.D.

Senior Vice President of Translational & Nonclinical Research

Raju S. Mohan Ph.D.CEO

Founder, Chief Executive Officer, President & Director

Matthew Richard MooreCOO

Chief Operating Officer

Snehal Naik Ph.D.

Senior Vice President of Clinical Development

Management

Roy M. Gonzales CPA, M.B.A.

Senior Vice President of Finance and Principal Financial & Accounting Officer

Mark S. Forman M.D., Ph.D.

Chief Medical Officer

Sheila K. Gujrathi M.D.

Executive Chairperson

John M. Nuss Ph.D.

Chief Scientific Officer

Kathy Ogilvie Ph.D.

Senior Vice President of Translational & Nonclinical Research

Raju S. Mohan Ph.D.CEO

Founder, Chief Executive Officer, President & Director

Matthew Richard MooreCOO

Chief Operating Officer

Snehal Naik Ph.D.

Senior Vice President of Clinical Development

Total 8 executives

VTYX Frequently asked questions

What is Ventyx Biosciences, Inc. (VTYX) Stock Price?

Current stock price of Ventyx Biosciences, Inc. (VTYX) stock is $14.000. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Ventyx Biosciences, Inc. (VTYX) stock is 5.40M.

Last updated at 06 Mar 2026, 02:30 pm.

Why is the Ventyx Biosciences, Inc. (VTYX) stock price going up or down today?

The stock price of Ventyx Biosciences, Inc. (VTYX) can change with earnings, company news, and overall market sentiment. Ventyx Biosciences, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ventyx Biosciences, Inc. stock expensive at its current price?

Whether Ventyx Biosciences, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VTYX on this page is -9.40. EPS on this page is -1.49. Compare those figures with peers and growth expectations before deciding if the current Ventyx Biosciences, Inc. price is justified.

How has the stock price of Ventyx Biosciences, Inc. (VTYX) performed historically?

Historical performance for Ventyx Biosciences, Inc. (VTYX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VTYX reacted to past earnings and market events.

Should I buy Ventyx Biosciences, Inc. (VTYX) stock, at this price?

Buying Ventyx Biosciences, Inc. (VTYX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.